Xadago | DrugsbyCanada

Xadago (safinamide), known as Onstryv in Canada, is available in 50 mg and 100 mg tablet strengths to support Parkinson’s disease management. These tablets, sourced from Canada, meet strict Canadian regulatory standards to ensure safety and efficacy. The packaging includes bilingual English and French labeling, as required in Canada, and features a unique 8-digit Drug Identification Number (DIN), confirming Health Canada approval. By choosing Canadian-sourced Xadago, patients can trust in the quality and authenticity of their medication while accessing cost savings.